“Lipid–Polymer Hybrid Nanoparticles for Depression Therapy: A Novel Strategy for Enhanced Brain Drug Delivery” (2025) Journal of Drug Delivery and Biotherapeutics, 2(2), pp. 17–24. doi:10.61920/tqfc1w78.